The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic patterns plus clinical and molecular characteristics of ROS1 aberrations in non-small cell lung cancer patients without rearrangements.
 
Moritz Glaser
No Relationships to Disclose
 
Cornelia von Levetzow
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
Honoraria - AstraZeneca; Janssen Oncology; Merck KGaA; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis
 
Lucia Nogova
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Dracen (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Janssen; Novartis; Pfizer
 
Marianna Katzenmeier
No Relationships to Disclose
 
Claudia Wompner
No Relationships to Disclose
 
Jaqueline Schmitz
No Relationships to Disclose
 
Elisabeth Bitter
No Relationships to Disclose
 
Inken Terjung
No Relationships to Disclose
 
Elke Passmann
No Relationships to Disclose
 
Diana Schaufler
Employment - BMS Brazil
 
Anna Eisert
No Relationships to Disclose
 
Rieke Nila Fischer
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Research Funding - Bristol-Myers Squibb (Inst)
 
Richard Riedel
No Relationships to Disclose
 
Jan-Phillip Weber
Employment - Lilly
 
Sabine Hahne
No Relationships to Disclose
 
Sabine Merkelbach-Bruse
No Relationships to Disclose
 
Reinhard Büttner
No Relationships to Disclose
 
Juergen Wolf
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma Europe; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo; Loxo/Lilly; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo Europe GmbH; Ignyta; Janssen; Lilly; Loxo/Lilly; MSD Oncology; Novartis; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Matthias Scheffler
Employment - Takeda